Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESRIX trial of autologous adipose-derived mesenchymal stem cells for radiation-induced xerostomia
2014-004349-29Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Feb 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of autologous adipose-derived mesenchymal stromal cells in xerostomia and hyposalivation (2 arms), sponsored by Rigshospitalet. Primary endpoint: Safety. Started Feb 2015; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
xerostomiahyposalivation
Beyond the preview
Go deeper on 2014-004349-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004349-29.